Skip to main content
Clinical Trials/NCT02267577
NCT02267577
Completed
Not Applicable

Accuracy Assessment of an Automatic Blood Pressure Measurement Device in Adult Volunteers

William Marsh Rice University1 site in 1 country90 target enrollmentJanuary 2015
ConditionsPre Eclampsia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pre Eclampsia
Sponsor
William Marsh Rice University
Enrollment
90
Locations
1
Primary Endpoint
Percentage of Sphygmo Readings That Were With < 5 mmHg, < 10 mmHg, and < 15 mmHg of the Readings by the Gold Standard Sphygmomanometer.
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The research team has developed an automatic blood pressure monitor (Sphygmo) to be used for the monitoring and diagnosis of pre-eclampsia in pregnant women, particularly in low-resource settings where current monitoring is limited.

90 adult volunteers will be enrolled by researchers at Rice University. The participant will be seated in a comfortable chair with arm at heart level. Arm circumference will be measured and a blood pressure cuff will be placed on the arm. The cuff will be inflated and blood pressure measurements will be taken by a commercially available device and by the Sphygmo device. Blood pressure measurements from both devices will be recorded. The participant's blood pressure will be measured up to 9 times with a waiting period of 45-60 seconds between each measurement.

The results of this study will be used to optimize the blood pressure detection algorithm and thus further develop the device.

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
October 12, 2017
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Rebecca Richards-Kortum

Stanley C. Moore Professor of Bioengineering

William Marsh Rice University

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • Willing and able to provide informed consent

Exclusion Criteria

  • Unable to provide informed consent

Outcomes

Primary Outcomes

Percentage of Sphygmo Readings That Were With < 5 mmHg, < 10 mmHg, and < 15 mmHg of the Readings by the Gold Standard Sphygmomanometer.

Time Frame: Blood pressure was measured an average of 9 times for each participant during their single visit and the mean of these measurements was recorded and used for analysis. The measurement period lasted approximately 30-45 minutes.

The British Hypertension society defines a specific criteria for the accuracy of a sphygmomanometer. Devices are graded according to the cumulative percentage of readings that have an absolute difference between the more favorable observer's mercury sphygmomanometer readings and the test device of \< 5 mmHg, \< 10 mmHg, and \< 15 mmHg. A letter grade of "A" requires that over 60%, 85%, and 95% were achieved in the \< 5 mmHg, \< 10 mmHg, and \<15 mmHg categories, respectively. A letter grade of "B" requires that over 50%, 75%, and 90% were achieved in the \< 5 mmHg, \< 10 mmHg, and \<15 mmHg categories, respectively. The test device achieved a grade of (B/B) with the validation data from this study.

Accuracy of Blood Pressure Measurement by Sphygmo Relative to the Clinical Standard.

Time Frame: Blood pressure was measured an average of 9 times for each participant during their single visit and the mean of these measurements was recorded and used for analysis. The measurement period lasted approximately 30-45 minutes.

Mean difference of systolic and diastolic blood pressure readings between Sphygmo device and the gold standard sphygmomanometer.

Study Sites (1)

Loading locations...

Similar Trials